Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

September 30, 1998

Primary Completion Date

August 31, 2000

Study Completion Date

August 31, 2000

Conditions

Sarcoma

Interventions

DRUG

cyclophosphamide

DRUG

dexrazoxane hydrochloride

DRUG

disaccharide tripeptide glycerol dipalmitoyl

DRUG

doxorubicin hydrochloride

DRUG

vincristine sulfate

PROCEDURE

surgical procedure

RADIATION

radiation therapy

Trial Locations (2)

Memorial Sloan-Kettering Cancer Center, New York

University of Texas - MD Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003667 - Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma | Biotech Hunter | Biotech Hunter